MoneyWorks4Me

Solara Active Pharma Sciences informs about conference call

16 Jan 2025 Evaluate
Solara Active Pharma Sciences has informed that Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Friday, January 24, 2025, at 3:30 pm IST to discuss the Company's financial results for the quarter and nine months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

630.05 -11.60 (-1.81%)
03-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.00
Dr. Reddys Labs. 1155.00
Cipla 1389.00
Lupin 2135.00
Zydus Lifesciences 1135.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: